Overview

Airway Inflammation In Patients With Chronic Obstructive Pulmonary Disease

Status:
Completed
Trial end date:
2003-12-01
Target enrollment:
Participant gender:
Summary
This study was designed to look at effects of salmeterol/fluticasone propionate compared to placebo on airway inflammation in patients with chronic obstructive airways disease
Phase:
Phase 3
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Fluticasone
Salmeterol Xinafoate
Xhance